menu
    • menu

    Company profile for Pelthos Therapeutics

    NEW Drugs in Dev: 2
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Pelthos Therapeutics is a biopharmaceutical company dedicated to delivering safe, effective therapies for patients with unmet medical needs. Its lead product, ZELSUVMI™ (berdazimer) topical gel, 10.3%, is FDA-approved for the treatment of molluscum contagiosum. Pelthos also advances a pipeline of product candidates powered by its proprietary nitric oxide-based platform, NITRICIL™, aiming to address various dermatological a...
    Pelthos Therapeutics is a biopharmaceutical company dedicated to delivering safe, effective therapies for patients with unmet medical needs. Its lead product, ZELSUVMI™ (berdazimer) topical gel, 10.3%, is FDA-approved for the treatment of molluscum contagiosum. Pelthos also advances a pipeline of product candidates powered by its proprietary nitric oxide-based platform, NITRICIL™, aiming to address various dermatological and infectious diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Pelthos TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4020 Stirrup Creek Drive Suite 110 Durham, NC 27703
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://pelthos.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pelthos Therapeutics Presents at Oppenheimer 36th Healthcare Conf
    Pelthos Therapeutics Presents at Oppenheimer 36th Healthcare Conf

    23 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/23/3242586/0/en/Pelthos-Therapeutics-to-Present-at-the-Oppenheimer-36th-Annual-Healthcare-Life-Sciences-Conference.html

    GLOBENEWSWIRE
    23 Feb 2026
    Share Share
    Horizon Technology Finance Offers $50M Venture Loan to Pelthos
    Horizon Technology Finance Offers $50M Venture Loan to Pelthos

    15 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260115051163/en/Horizon-Technology-Finance-Provides-up-to-%2450-Million-Venture-Loan-Facility-to-Pelthos-Therapeutics

    BUSINESSWIRE
    15 Jan 2026
    Share Share
    Pelthos Therapeutics Secures $50M Loan From Horizon Technology
    Pelthos Therapeutics Secures $50M Loan From Horizon Technology

    13 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/13/3217806/0/en/Pelthos-Therapeutics-Secures-Up-to-50-Million-Senior-Secured-Term-Loan-Facility-from-Horizon-Technology-Finance.html

    GLOBENEWSWIRE
    13 Jan 2026
    Share Share
    Pelthos Therapeutics Acquires Xeglyze For Head Lice Treatment
    Pelthos Therapeutics Acquires Xeglyze For Head Lice Treatment

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3212645/0/en/Pelthos-Therapeutics-Acquires-Xeglyze-abametapir-Topical-Treatment-for-Head-Lice.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share
    Pelthos Therapeutics Appoints Andrew Einhorn To Board
    Pelthos Therapeutics Appoints Andrew Einhorn To Board

    23 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/23/3210187/0/en/Pelthos-Therapeutics-Expands-Board-of-Directors-with-the-Appointment-of-Andrew-Einhorn.html

    GLOBENEWSWIRE
    23 Dec 2025
    Share Share
    Pelthos Pharma Inks Deal To Broaden ZELSUVMI Gel Access
    Pelthos Pharma Inks Deal To Broaden ZELSUVMI Gel Access

    04 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/04/3199638/0/en/Pelthos-Therapeutics-Signs-Major-Pharmacy-Benefit-Manager-Agreement-Expanding-Patient-Access-to-ZELSUVMI-berdazimer-Topical-Gel-10-3.html

    GLOBENEWSWIRE
    04 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search